The nationwide withdrawal, affecting roughly 1 million people in the United States, comes amid chaos in the government health ...

Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...

Payer profits fell in 2024 as Americans, especially older ones, utilized more medical care. But efforts to resuscitate ...

In this week’s edition of InnovationRx, we look at Aetna’s withdrawal from the ACA exchanges, the potential for digital ...

CVS stock has an attractive yield and earnings expansion. That makes it worth a look for investors seeking growth and income.

In recent decades, Rite Aid seemed to zig when it should have zagged.

CVS Health (CVS) stock in focus as Glenview Capital trims a third of its stake after the company's Q1 2025 earnings beat.

Renaissance Life & Health Insurance Company of America and Ansel Health are rolling out RenSecureHealth, a new ...

This bankruptcy is more final than the one Rite Aid filed in 2023. Rather than just a financial reorganization, the company is putting its remaining 1,200-plus brick-and-mortar locations — down from ...

Pharmacology has been at it a long time. Precursor to the Western pill-based prescription for all that ails, it stands on the shoulders of a thousands-generations long compilation of the knowledge of ...